[ET Net News Agency, 14 July 2021] CSPC PHARMA (01093) rose 4.37% to HK$10.98, breaking
above the 10-D SMA of HK$10.513.
It hits an intra-day high of HK$11.06, and an intra-day low of HK$10.5. The total shares
traded was 31.44 million, with a value of HK$340.73m. The active buy/sell ratio is 54:46,
with net buying turnover of HK$23.38m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$27.1m, with volume weighted average price of HK$10.878.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$15.65m, with
volume weighted average price of HK$10.901. The stock has risen a combined 8.71% over the
past 4 consecutive trading days.
The Hang Seng Index now fell 181 points, or 0.65% to 27,782; the Hang Seng China
Enterprises Index now fell 50 points, or 0.5% to 10,063; the Hang Seng TECH Index now rose
12 points, or 0.16% to 7,672; with an overall turnover of HK$84.79b.
The SSE Composite Index now fell 27 points, or 0.78% to 3,538, with an overall turnover
of RMB335.54b.
The SZSE Component Index now fell 50 points, or 0.33% to 15,139, with an overall
turnover of RMB240.65b.
Basic Information
-------------------------------------------
Nominal 10.980 % Chg +4.37%
High 11.060 Low 10.500
Shares Tr 31.44m Turnover 340.73m
10-D SMA 10.513 %H.V 44.690
20-D SMA 11.044 VWAP 10.838
50-D SMA 11.097 RSI14 49.902
-------------------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 54:46, with net buying
turnover of HK$23.38m, rising a combined 8.71% over the past 4 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
CSPC PHARMA (01093) 10.98 +4.37
SIHUAN PHARM (00460) 3.07 +11.64
CHINAGRANDPHARM (00512) 6.95 Unchanged
CMS (00867) 18.98 +0.11
SINO BIOPHARM (01177) 7.24 +2.99
3SBIO (01530) 8.41 +2.56
FOSUN PHARMA (02196) 57.30 +2.32
WUXI APPTEC (02359) 181.60 +2.43
HANSOH PHARMA (03692) 31.80 +1.92
PHARMARON (03759) 198.40 +2.01
-------------------------------------------------
(ed)